Technology Insight: identification of biomarkers with tissue microarray technology (original) (raw)
Battifora H (1986) The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest55: 244–248 CASPubMed Google Scholar
Wan WH et al. (1987) A rapid and efficient method for testing immunohistochemical reactivity of monoclonal antibodies against multiple tissue samples simultaneously. J Immunol Methods103: 121–129 ArticleCAS Google Scholar
Kononen J et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med4: 844–847 ArticleCAS Google Scholar
Rimm DL et al. (2001) Tissue microarray: a new technology for amplification of tissue resources. Cancer J7: 24–31 CAS Google Scholar
Chung CH et al. (2002) Molecular portraits and the family tree of cancer. Nat Genet32 (Suppl): 533–540 ArticleCAS Google Scholar
van de Rijn M and Gilks CB (2004) Applications of microarrays to histopathology. Histopathology44: 97–108 ArticleCAS Google Scholar
Bertucci F et al. (2004) Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene23: 1377–1391 ArticleCAS Google Scholar
Dhanasekaran SM et al. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature412: 822–826 ArticleCAS Google Scholar
Moch H et al. (1999) High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol154: 981–986 ArticleCAS Google Scholar
Sallinen SL et al. (2000) Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res60: 6617–6622 CASPubMed Google Scholar
Hans CP et al. (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood103: 275–282 ArticleCAS Google Scholar
Rhodes A et al. (2002) A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. Am J Clin Pathol117: 81–89 ArticleCAS Google Scholar
Want R (2004) RFID. A key to automating everything. Sci Am290: 56–65 Article Google Scholar
Garcia JF et al. (2003) Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood101: 681–689 ArticleCAS Google Scholar
Nocito A et al. (2001) Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol194: 349–357 ArticleCAS Google Scholar
Camp RL et al. (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest80: 1943–1949 ArticleCAS Google Scholar
Hendriks Y et al. (2003) Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol162: 469–477 ArticleCAS Google Scholar
Leversha MA et al. (2003) Expression of p53, pRB, and p16 in lung tumours: a validation study on tissue microarrays. J Pathol200: 610–619 ArticleCAS Google Scholar
Engellau J et al. (2001) Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma. Appl Immunohistochem Mol Morphol9: 358–363 CASPubMed Google Scholar
Schraml P et al. (1999) Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res5: 1966–1975 CASPubMed Google Scholar
Torhorst J et al. (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol159: 2249–2256 ArticleCAS Google Scholar
Rubin MA et al. (2002) Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol26: 312–319 Article Google Scholar
McCarty KS Jr et al. (1986) Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res46 (Suppl): S4244–S4248 Google Scholar
Harvey JM et al. (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol17: 1474–1481 ArticleCAS Google Scholar
Wang S et al. (2001) Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol116: 495–503 ArticleCAS Google Scholar
Sauter G et al. (2003) Tissue microarrays in drug discovery. Nat Rev Drug Discov2: 962 ArticleCAS Google Scholar
Simon R and Sauter G (2003) Tissue microarray (TMA) applications: implications for molecular medicine. Expert Rev Mol Med2003: 1–12 Google Scholar
Jubb AM (2003) Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization. J Pathol200: 577–588 ArticleCAS Google Scholar
Camp RL et al. (2002) Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med8: 1323–1327 ArticleCAS Google Scholar
Camp RL et al. (2003) Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome. Cancer Res63: 1445–1448 CASPubMed Google Scholar
Berger A et al. Automated Quantitative Analysis (AQUA) of HDM2 Expression in Malignant Melanoma Shows Association with Early Stage Disease and Improved Outcome. Cancer Res, in press
Rubin MA et al. (2004) Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements. Am J Pathol164: 831–840 ArticleCAS Google Scholar
Simon R et al. (2003) Tissue microarrays in cancer diagnosis. Expert Rev Mol Diagn3: 421–430 ArticleCAS Google Scholar
Hammond ME and Taube SE (2002) Issues and barriers to development of clinically useful tumor markers: a development pathway proposal. Semin Oncol29: 213–221 Article Google Scholar
Press MF et al. (2002) Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol20: 3095–3105 ArticleCAS Google Scholar
Barker PE (2003) Cancer biomarker validation: standards and process: roles for the National Institute of Standards and Technology (NIST). Ann N Y Acad Sci983: 142–150 ArticleCAS Google Scholar
Sullivan Pepe M et al. (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst93: 1054–1061 Article Google Scholar
Alkushi A et al. (2003) Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Archiv442: 271–277 CASPubMed Google Scholar
Chung GG et al. (2004) beta-Catenin and p53 analyses of a breast carcinoma tissue microarray. Cancer100: 2084–2092 ArticleCAS Google Scholar
Barlund M et al. (2000) Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Res60: 5340–5344 CASPubMed Google Scholar
Chung GG et al. (2001) Tissue microarray analysis of beta-catenin in colorectal cancer shows nuclear phospho-beta-catenin is associated with a better prognosis. Clin Cancer Res7: 4013–4020 CASPubMed Google Scholar
Alonso SR et al. (2004) Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol164: 193–203 ArticleCAS Google Scholar
Bubendorf L et al. (1999) Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res59: 803–806 CASPubMed Google Scholar
Makretsov N et al. (2004) Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast cancer. Clin Cancer Res10: 6143–6151 ArticleCAS Google Scholar
Nishizuka S et al. (2003) Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res63: 5243–5250 CASPubMed Google Scholar